You are on page 1of 2

Mr C.

RAJASHEKAR REDDY(19161) APL Code : APD-TS-173 Sample Type : SERUM


Age : 55 Year(s) Male Ref Doctor: SID : 708334
Customer :
Collected on : 2021-08-19 23:18

█▐ ▌▐█▐▌█▌▌▐█▐▌▐█▐ █ █ ▌█▌▐▌▐▐█ █ ▌▐█▐ █ ▌ █ ▐█▐▐▌


Regd on : 2021-08-20 11:16
█▐ ▌▐█▐▌█▌▌▐█▐▌▐█▐ █ █ ▌█▌▐▌▐▐█ █ ▌▐█▐ █ ▌ █ ▐█▐▐▌
█▐ ▌▐█▐▌█▌▌▐█▐▌▐█▐ █ █ ▌█▌▐▌▐▐█ █ ▌▐█▐ █ ▌ █ ▐█▐▐▌
█▐
█▐
█▐
▌▐█▐▌█▌▌▐█▐▌▐█▐
▌▐█▐▌█▌▌▐█▐▌▐█▐
▌▐█▐▌█▌▌▐█▐▌▐█▐






▌█▌▐▌▐▐█
▌█▌▐▌▐▐█
▌█▌▐▌▐▐█



▌▐█▐
▌▐█▐
▌▐█▐









▐█▐▐▌
▐█▐▐▌
▐█▐▐▌
Reported On : 2021-08-20 20:05
█▐ ▌▐█▐▌█▌▌▐█▐▌▐█▐ █ █ ▌█▌▐▌▐▐█ █ ▌▐█▐ █ ▌ █ ▐█▐▐▌

IMMUNOASSAY

Test Description Result Units Biological Reference Ranges

SARS CoV 2 Antibody profile


SARS-CoV-2 IgG Antibody to Spike protein 5.27 AU/mL < 10.0 : Non-Reactive
(Method: Chemiluminescence)
> 10.0 : Reactive

Kit used: SARS-COV-2 IgG, Manufactured by : Beckman Coulter.


Uses monoclonal anti-human IgG alkaline phosphatase.
Specification : Specificity : 99.8% & Sensitivity : 100%

Dr S.V.RAMANA
Ch.Samuel
MD PATHOLOGIST
Manager Technical

This is an electronically authenticated report. Report printed date : 21/08/2021 18:44 Page 1 of 2
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
Report #
Mr C.RAJASHEKAR REDDY(19161) APL Code : APD-TS-173 Sample Type : SERUM
Age : 55 Year(s) Male Ref Doctor: SID : 708334
Customer :
Collected on : 2021-08-19 23:18

█▐ ▌▐█▐▌█▌▌▐█▐▌▐█▐ █ █ ▌█▌▐▌▐▐█ █ ▌▐█▐ █ ▌ █ ▐█▐▐▌


Regd on : 2021-08-20 11:16
█▐ ▌▐█▐▌█▌▌▐█▐▌▐█▐ █ █ ▌█▌▐▌▐▐█ █ ▌▐█▐ █ ▌ █ ▐█▐▐▌
█▐ ▌▐█▐▌█▌▌▐█▐▌▐█▐ █ █ ▌█▌▐▌▐▐█ █ ▌▐█▐ █ ▌ █ ▐█▐▐▌
█▐
█▐
█▐
▌▐█▐▌█▌▌▐█▐▌▐█▐
▌▐█▐▌█▌▌▐█▐▌▐█▐
▌▐█▐▌█▌▌▐█▐▌▐█▐






▌█▌▐▌▐▐█
▌█▌▐▌▐▐█
▌█▌▐▌▐▐█



▌▐█▐
▌▐█▐
▌▐█▐









▐█▐▐▌
▐█▐▐▌
▐█▐▐▌
Reported On : 2021-08-20 20:05
█▐ ▌▐█▐▌█▌▌▐█▐▌▐█▐ █ █ ▌█▌▐▌▐▐█ █ ▌▐█▐ █ ▌ █ ▐█▐▐▌

IMMUNOLOGY

Test Description Result Units Biological Reference Ranges

SARS CoV 2 Antibody profile


SARS CoV-2 (COVID 19)Antibody Total 7.96 Units <9 : Negative
(Method: ELISA)
9 - 11 : Equivocal
> 11 : Positive

This test detects the presence of antibodies to Covid -19 in the specimen and should not be used as
the sole criteria for the diagnosis of Covid-19 infection.As with all diagnostic tests ,all results must be
correlated with other clinical finds.A negative result at any time does not preclude the possibility of an
early infection of Covid-19 infection.This is only screening test.Therefore,other more specific test like
PCR method must be used in order to obtain a confirmation of Covid-19 infection.

Dr.S.M.DEVARA
Ch.Samuel
MD MICROBIOLOGIST
Manager Technical

This is an electronically authenticated report. Report printed date : 21/08/2021 18:44 Page 2 of 2
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
Report #

You might also like